Stonegate Capital Partners Updates Coverage on OS Therapies Inc. (OSTX) 3Q25 [Yahoo! Finance]
OS Therapies to spin off OS Animal Health into a standalone public company [Seeking Alpha]
OS Therapies to Spinoff OS Animal Health into Standalone Public Company [Yahoo! Finance]
OS Therapies GAAP EPS of -$0.21 misses by $0.08 [Seeking Alpha]
OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully-Resected, Pulmonary Metastatic Osteosarcoma [Yahoo! Finance]